Amgen to team with Eli Lilly on COVID treatment
Thousand Oaks biotech giant Amgen announced another strategy to help address the coronavirus pandemic, entering into a manufacturing agreement with Eli Lilly to produce COVID-19 antibodies. Eli Lilly, based in Indianapolis, has been pursuing several antibody treatments for the virus, the two companies said in a Sept. 17 news release. With access to Amgen’s manufacturing Read More →
UCSB, Cal Poly, CLU all make top 10 in U.S. News rankings
UC Santa Barbara placed No. 30 on U.S. News & World Report’s latest ranking of national universities and sixth among public universities, one of three Central Coast colleges in the top 10 in its category. U.S. News released its annual “Best Colleges” lists for 2021 on Sept. 14, with the six colleges in the Tri-Counties Read More →
AeroVironment’s revenue up, profit down
AeroVironment, the Simi Valley-based drone maker, said revenue in its first quarter grew slightly to $87.4 million as the company’s profit fell to 42 cents per share from 71 cents a year earlier. “We are on track to achieve our fiscal year 2021 plans and deliver another year of profitable top line growth, despite the Read More →
Amgen to join exclusive Dow Jones club
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen teams up with competitors in COVID treatment trial
Amgen has joined two of its competitors in launching a trial for drugs to treat patients with COVID-19. Together with Chicago-based AbbVie and Japanese drugmaker Takeda Pharmaceutical, the Thousand Oaks biotech giant said Aug. 3 it had enrolled the first patients into a clinical trial for the anti-inflammatory drugs Otezla, cenicriviroc and Firazyr. Otezla is Read More →